HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Christopher Boivin Selected Research

N-(2-hydroxypropyl)methacrylamide co-polymer-doxorubicin conjugate

6/2009Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Christopher Boivin Research Topics

Disease

3Neoplasms (Cancer)
06/2009 - 09/2004
1Breast Cancer 3
06/2009
1Breast Neoplasms (Breast Cancer)
06/2009
1Colorectal Neoplasms (Colorectal Cancer)
06/2009
1Neoplasm Metastasis (Metastasis)
11/2005

Drug/Important Bio-Agent (IBA)

1Doxorubicin (Adriamycin)FDA LinkGeneric
06/2009
1AnthracyclinesIBA
06/2009
1PolymersIBA
06/2009
1N-(2-hydroxypropyl)methacrylamide co-polymer-doxorubicin conjugateIBA
06/2009
1Amino AcidsFDA Link
11/2005
1Proteins (Proteins, Gene)FDA Link
11/2005
1Laminin ReceptorsIBA
09/2004

Therapy/Procedure

1Therapeutics
06/2009